2020 ANS Virtual Winter Meeting: Medical isotopes production and applications

November 16, 2020, 5:28PMNuclear News

The Monday session “Advancement in Medical Isotopes Production and Applications” of the 2020 ANS Virtual Winter Meeting was sponsored by the Isotopes & Radiation Division and co-chaired by Lin-Wen Hu of Massachusetts Institute of Technology and James Bowen of Pacific Northwest National Laboratory.

Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. Technetium-99m (decay product of molybdenum-99), for example, is used in more than 80 percent of nuclear medicine diagnostic procedures. The session featured speakers who discussed the advancement and status of domestic production and applications of medical isotopes.

To continue reading, log in or create a free account!

Related Articles

NNSA’s CIRP checks Kansas off its list

September 12, 2025, 6:56AMNuclear News

Kansas in now one of 11 U.S. states and territories that is free of cesium-137 irradiators—the others being Alaska, Arizona, Delaware, Idaho, Iowa, Nevada, New Mexico, Puerto Rico, South...

Deep Fission raises $30M in financing

September 8, 2025, 3:13PMNuclear News

Since the Department of Energy kicked off a 10-company race with its Nuclear Reactor Pilot Program to bring test reactors on line by July 4, 2026, the industry has been waiting for new...

Aalo breaks ground in Idaho

September 3, 2025, 7:01AMNuclear News

Eight days after Aalo Atomics released the details of its securing of $100 million in Series B funding, the company announced that it has broken ground on the 50-MWe Aalo-X. Sited in the...